Currus Biologics

Currus Biologics is a privately held biotechnology company based in Melbourne, Australia, developing CAR T-cell therapies for solid tumours using its proprietary BEAT technology. The company was founded in 2021 and is funded by Brandon Capital Partners, Uniseed, and Main Sequence Ventures. Currus Biologics was spun out of research from the Peter MacCallum Cancer Centre, a world-leading cancer research and treatment centre.